CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results and Announces Nadim Yared Retirement Plans
MINNEAPOLIS, Jan. 08, 2024 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ:CVRX) (“CVRx”), a commercial-stage medical device company, announced today certain preliminary unaudited fourth quarter and full year 2023 revenue results as well as its 2024 business outlook. The Company also announced that President and Chief Executive Officer, Nadim Yared, has informed the Board of Directors of his plans to retire following the selection and appointment of his successor.
Related news for (CVRX)
- CVRx Announces Positive News on Outpatient Payment for Barostim
- 24/7 Market News Snapshot 16 July, 2025 – CVRx, Inc. Common Stock (NASDAQ:CVRX)
- CVRx Reports Preliminary First Quarter 2025 Financial Results
- CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2024 Financial Results and Issues Fiscal 2025 Guidance
- CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025